NDC11 63323034941

This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.

Possible FDA NDC forms#

Package NDC, Product root table
Package NDC	Product root
63323-0349-41	63323-0349
63323-349-41	63323-349

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Imipenem and Cilastatin	IMIPENEM AND CILASTATIN SODIUM	Fresenius Kabi USA, LLC	ce771566-c4f2-447e-944a-6b908925c90b	2022-10-11	Warnings, Adverse reactions	Exact identifier ndc (product): 63323-349
Imipenem and Cilastatin	IMIPENEM AND CILASTATIN SODIUM	Fresenius Kabi USA, LLC	0a1dd9b9-ada1-4bff-9dcb-18961254e9e8	2022-10-10	Warnings, Adverse reactions	Exact identifier ndc (package): 63323-349-41 ndc (product): 63323-349 ndc11 (package): 63323034941
Imipenem and Cilastatin	IMIPENEM AND CILASTATIN SODIUM	Fresenius Kabi USA, LLC	6ab0ca9e-9a79-4cab-9f09-470eda06952e	2022-10-06	Warnings, Adverse reactions	Exact identifier ndc (product): 63323-349

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.